Alpha Tau Medical Statistics
Total Valuation
DRTS has a market cap or net worth of $331.68 million. The enterprise value is $272.97 million.
Important Dates
The last earnings date was Thursday, November 20, 2025, after market close.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DRTS has 85.26 million shares outstanding. The number of shares has increased by 9.73% in one year.
| Current Share Class | 85.26M |
| Shares Outstanding | 85.26M |
| Shares Change (YoY) | +9.73% |
| Shares Change (QoQ) | +5.97% |
| Owned by Insiders (%) | 16.12% |
| Owned by Institutions (%) | 2.15% |
| Float | 57.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.28 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.43, with a Debt / Equity ratio of 0.17.
| Current Ratio | 8.43 |
| Quick Ratio | 7.90 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -41.97 |
Financial Efficiency
Return on equity (ROE) is -54.38% and return on invested capital (ROIC) is -28.86%.
| Return on Equity (ROE) | -54.38% |
| Return on Assets (ROA) | -25.56% |
| Return on Invested Capital (ROIC) | -28.86% |
| Return on Capital Employed (ROCE) | -41.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$319,736 |
| Employee Count | 125 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, DRTS has paid $158,000 in taxes.
| Income Tax | 158,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.67% in the last 52 weeks. The beta is 1.07, so DRTS's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +29.67% |
| 50-Day Moving Average | 3.98 |
| 200-Day Moving Average | 3.26 |
| Relative Strength Index (RSI) | 50.48 |
| Average Volume (20 Days) | 61,959 |
Short Selling Information
The latest short interest is 120,842, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 120,842 |
| Short Previous Month | 90,302 |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.21% |
| Short Ratio (days to cover) | 1.92 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.96M |
| Pretax Income | -39.81M |
| Net Income | -39.97M |
| EBITDA | -38.84M |
| EBIT | -39.96M |
| Earnings Per Share (EPS) | -$0.52 |
Full Income StatementBalance Sheet
The company has $72.21 million in cash and $13.50 million in debt, giving a net cash position of $58.71 million or $0.69 per share.
| Cash & Cash Equivalents | 72.21M |
| Total Debt | 13.50M |
| Net Cash | 58.71M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 77.58M |
| Book Value Per Share | 0.91 |
| Working Capital | 67.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |